This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Fred Wilson wrote a Tweetstorm and then did a blog post on the topic. I never asked Marc why he stopped blogging but I presume it is some combo of having started a venture capital firm (which you might guess takes a bit of time) and also allowing some air time for his then-less-well-known compadre. Engagement. They are synergistic.
Tracy studied SEOMoz and several other online sources of SEO tips. So Tracy began keeping a blog about … (what else?) She became an authority on the topic and her blog helped her to both elevate her status in her industry as well as to bring great link juice to her website and improve her SEO.
So they create a task list of all the marketing activities an organization can do: press releases, web site updates, customer case studies, blog posts, daily Tweets, Facebook fan page, attending conferences, etc. They’re tasked with doing … marketing. You get a lot of traffic – not always results.
This blog started from a series of conversations I found myself having over and over again with founders and eventually decided I should just start writing them.It He wants to compete to be the lead drummer in the competitive ensemble and study under Terence, an obsessive instructor who is hell bent on winning competitions for the school.
Preliminary findings from an economic impact study show that genomics is emerging as a distinct innovation cluster in San Diego. Final results of the EDC study won’t be released until June 19, the first day of the Bio International Convention, as part of a panel discussion on the local genomics cluster.
He studied the errors that other people had made and tried to improve on them. Authenticity - I asked Chamillionaire why he thinks he connects so much with people at tech conferences. I had written a blog post on exactly this – how to not suck at group presentations – and what he said reminded me a lot of this post.
At the American Psychiatric Association conference today in New York, Assurex Health, a division of diagnostics firm Myriad Genetics (NASDAQ: MYGN ), is releasing data from a study of 1,167 people with serious depression, officially known as major depressive disorder, whom previous treatments have failed.
Sometimes I make a blog entry. Some days I respond to questions asked by folks like yourself, the press, or an entity doing a case study, i.e. Citrix, RIM, USC. You've been blogging for a while, what are five good posts that I should check out? My company and I are a perfect case study for the Tech Council affiliation.
By the way, I don’t spell check my blog posts either. Sometimes when I speak at conferences I’ll stay and shake hands for 2 hours with anybody who wants to say hello. Some days I’m in back-to-back meetings and then I have a late night work dinner and an early morning conference call. I’m not an elitist a **e.
The European Society for Medical Oncology is wrapping up its annual conference today, replete with clinical data from cancer’s front lines. Breast Cancer Patients with two different types of breast cancer got promising news at ESMO from studies exploring relatively new methods of treatment. [ Ben Fidler co-authored this report.]
I commented briefly on his blog and made a mental note to write a blog post. Two weeks after Brad’s post I was at the 140 Conference in LA and I held open office hours for any entrepreneur who wanted to spend 15 minutes talking with a VC about their business. I hope that didn’t have a stature of limitation!
A Roche drug in development as a treatment for spinal muscular atrophy achieved the main goals of a key study, helping to build the case that the drug could challenge a Biogen therapy already approved for the rare disorder. The Basel, Switzerland-based company plans to present full data from the study at a future medical conference.
This weekend, San Diego will host the annual American Society of Hematology conference, the largest U.S. medical gathering to get the latest on blood diseases, and a venue for updates on some of the most cutting-edge biotechnologies that only a few years ago seemed like science fiction.
It does mean that you need to look, listen, and participate in the business world around you, and network through all available channels, like business-oriented social networks online (LinkedIn), local business organizations (Chamber of Commerce), and events or conferences in your school or industry. Don’t skip all business social settings.
Studies have shown that work productivity is related to a happier work culture , and customer satisfaction and loyalty are also dependent on the culture. Use marketing, blogging, and industry conferences to get the message out. Here are the key elements I see: Make your company culture virtual.
I wrote a blog post related to this called Is it Time to Earn or to Learn? And, of course, I check incessantly when I travel, am waiting for a meeting or am sitting in a conference. If you always planned to study a second language – START! So in that context let me use it. Blackberry satisfies this addiction.
Organovo unveiled its plans to develop “therapeutic” tissue after showing in preclinical animal studies that bio-printed liver patches successfully grafted, formed blood vessels, and functioned normally, according to a statement today. The conference is making a webcast of his presentation available here. liver transplant waiting list.
This goes into the heart of my controversial blog post (coming soon! Come back to this blog over the next 2 weeks and I’ll explain. even if it’s just a web conference call walk through. Sometimes I encourage teams to create new analysis on cohorts, future revenue projections, competitor reviews, pricing studies, etc.
It does mean that you need to look, listen, and participate in the business world around you, and network through all available channels, like business-oriented social networks online (LinkedIn), local business organizations (Chamber of Commerce), and events or conferences in your domain. Don’t skip all business social settings.
It does mean that you need to look, listen, and participate in the business world around you, and network through all available channels, like business-oriented social networks online (LinkedIn), local business organizations (Chamber of Commerce), and events or conferences in your school or industry. Don’t skip all business social settings.
It does mean that you need to look, listen, and participate in the business world around you, and network through all available channels, like business-oriented social networks online (LinkedIn), local business organizations (Chamber of Commerce), and events or conferences in your domain. Don’t skip all business social settings.
Ciara Kennedy, who succeeded Mike Grey as Amplyx CEO late last year, said in an interview with Xconomy that the company plans to report results of its Phase 1 study at IDWeek, the annual infectious diseases conference that is set for early October in San Diego. But raising $67.
It does mean that you need to look, listen, and participate in the business world around you, and network through all available channels, like business-oriented social networks online (LinkedIn), local business organizations (Chamber of Commerce), and events or conferences in your domain. Don’t skip all business social settings.
Being in business since I was 18 years old has led to a lot of conferences, meetings, mixers, classes, tradeshows and after parties. It was at the South by Southwest Interactive conference in the media room when I overheard the founders being interviewed. Now study the event organizer. Blogs and Forums.
“We should couple innovation with biosecurity,” DARPA program manager Renee Wegrzyn, said Tuesday at the SynBioBeta conference in South San Francisco. ” At the conference, FBI supervisory special agent Ed You told the audience the bureau is aware of the need for new biosecurity measures.
The FDA didn’t smile upon a big submission of depression studies from Alkermes, while those fighting liver disease got a mixed slate of data as a big medical conference looms. After the deals, we’ll move on to data. There were plenty of policy and drug-price headlines, Read more » Reprints | Share:
Organovo said it also is collaborating on scientific studies of its kidney tissue technology as part of a continuing early access program that includes two big pharma companies. “We Organovo and others made additional presentations this week at the Eurotox 2016 scientific conference in Seville, Spain.
It does mean that you need to look, listen, and participate in the business world around you, and network through all available channels, like business-oriented social networks online (LinkedIn), local business organizations (Chamber of Commerce), and events or conferences in your school or industry. Don’t skip all business social settings.
Regulus reported that a second serious case of jaundice, or a yellowing of the skin and eyes, in a Phase 1 study of RG-101. Regulus said the hold won’t impact timelines for its three ongoing studies of RG-101, because it has already treated the patients in those trials—two Phase 2 studies and a single Phase 1 study.
It does mean that you need to look, listen, and participate in the business world around you, and network through all available channels, like business-oriented social networks online (LinkedIn), local business organizations (Chamber of Commerce), and events or conferences in your domain. Don’t skip all business social settings.
Ionis (NASDAQ: IONS ) and its partner, Cambridge, MA-based Biogen (NASDAQ: BIIB ), this morning reported an interim look at an ongoing Phase 3 study of nusinersen—an RNA-based drug meant to help treat patients with SMA. Ionis will complete the ongoing Phase 3 studies before transitioning everything to Biogen.
The Irvine Company also has created the ROC (as in Real Office Centers), a co-working space on the third floor that offers temporary offices, conference rooms, concierge services, high-speed Internet, and other business equipment and services. In April, a study released by the San Diego Regional Economic Development Corp.
The European Society for Medical Oncology’s annual conference wraps up in Copenhagen today. Clovis touted data from a “pooled” study of two mid-stage trials of rucaparib in ovarian cancer. —Novartis revealed in May that its breast cancer drug ribociclib did so well in a 668-patient Phase 3 trial that the study was halted early.
Kathy Sierra at Business of Software 2009 - Business of Software Blog , May 4, 2010 "In the old days, getting customers was easy. Draw Your Ideas - A VC : Venture Capital and Technology , May 16, 2010 I saw Jack Dorsey give this talk at The 99% Conference last month. saw Jack Dorsey give this talk at The 99% Conference last month.
In this article you’ll discover how to start a blog that makes money. There are four types of blogs; written blogs, video blogs, photo blogs and a combination of these. We’ll primarily be discussing written blogs. There are two different components to make money blogging. Let’s discuss. Not really.
Results from a big study are due Sept. 2 at a medical conference in Paris. Four years after approval the two PCSK9 blockers on the market have yet to crack $1 billion in annual sales, combined, thanks to a gloves-off effort by insurers to beat back their use. One of the two drugs might even be on life support.
It’s true this was much bigger in the dot com era but I’ve studied the data and know that over the past decade these numbers are right. The best VCs I know take 11pm conference calls. Most top tier VCs return about 3x invested capital and outlier funds (the best of a vintage) might return 6-8x. billion each, $7.5
But in Paris, this cardiologist will be in a conference center, walking an audience through a slide deck packed with Phase 3 data for a new cholesterol-lowering drug, inclisiran. You might be camping, barbecuing, or sleeping on Monday. It’s Labor Day, after all. Inclisiran’s owner, the Medicines Co.,
These are not networking events, summits or conferences where people exchange business cards, or meet-ups where we create opportunities to make contacts that further our careers. After a near death experience and much contemplation, I left the tech world and an amazing job to wander the planet. So, this is not a networking event?
Even as all eyes were on the American Society of Hematology (ASH) conference in downtown San Diego this week, other biotech companies were staying busy. Let’s get caught up with the latest life sciences news in San Diego.
Juno Therapeutics is still mulling next steps for its lead product, an experimental cancer immunotherapy now stuck in limbo because five of 68 adult leukemia patients in its current study, a clinical trial called “Rocket,” have died from severe brain swelling caused by the treatment.
—Cambridge-based Biogen (NASDAQ: BIIB ) published the results of an early stage study of closely watched Alzheimer’s disease drug aducanumab in the journal Nature. . —Staying in San Diego, Synthetic Genomics reported in Nature Methods that its scientists have re-engineered the salt-marsh-loving bacterium V.
—At the annual BIO conference, which gathered in San Francisco for the first time since cops battled street protesters in 2004, industry bigwigs took to the stage to defend themselves. Not against street riots this time, but against political, financial, and social pressures that are changing the way America pays for drugs.
Data from a hematology conference stoked dreams of approval, though still on a far horizon, for a couple drug makers. Familiar biotech names—not necessarily familiar for the right reasons—made news this week in biotech. Long anticipated, Walgreens officially cut ties with Theranos , and the FDA both gave and denied approvals.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content